R1 RCM Inc. which can be found using ticker (RCM) have now 14 confirmed analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 26 and 15 suggesting an average Analsyt target price of $19.04. Given that the stocks previous close was at $13.75 this now indicates there is a potential upside of 38.5%. There is a 50 day moving average of $13.83 and the 200 day MA is $16.82. The company has a market capitalization of $5,958m. Visit the company website at: https://www.r1rcm.com
The potential market cap would be $8,251m based on the market consensus.
R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and physician groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. R1 RCM Inc. was founded in 2003 and is headquartered in Murray, Utah.
The company is not paying dividends at this time.
